Furthermore, GTN lowers the levels of IL‐6, IL‐17, and TNF‐α in tumor tissue and prevents the activation of stromal immune cells and the nuclear translocation of NF‐κB (Vendramini‐Costa et al. 2017). The gene discussed is NFKB1; the disease is neoplasm.